Moderna Short Term We look to Sell at 133.52 (stop at 141.88) Preferred trade is to sell into rallies. Prices expected to stall near trend line resistance. Trades with a bearish descending triangle formation. Our overall sentiment remains bearish looking for lower levels. The bias is still for lower levels and we look for any gains to be limited. Our...
Moderna Short Term - We look to Sell at 149.49 (stop at 160.31) Preferred trade is to sell into rallies. Closed below the 20-day EMA. Trades with a bearish descending triangle formation. Our overall sentiment remains bearish looking for lower levels. We look to set shorts in the early trade. Our profit targets will be 123.84 and 103.50 Resistance: 150.00...
Bullish Flag on MRNA, Target Price 185 which is a swing high. Earning report was good, people use and need drugs and will continue to use and need.
We likely see a relief rally which will carry all stocks. We saw after hour that $FB missed earning but rallied anyway. Denmark announced today that it is ending all COVID treatment. thecountersignal.com Expect other progressive governments to follow suit - although their probably not that many anymore. Sure you could look at the excess deaths that...
You can see many supporting facts for my prediction on the chart... NASDAQ:MRNA
News - Better than expected Q4 EPS and sales results, the company expects to authorize a shares repurchase program up to 1.5B over the next two years. Levels -$195 is the next major resistance level. $138 is the next major support level. The stock is gapping up to $183 (pre-market). The idea is to go long at the open when it will try to test the $183 support...
Moderna ( NASDAQ:MRNA ) is in a falling wedge with no signs of escaping (yet). While it may have a small pop if there is good company news, the COVID-19 buying spree may be truly over. The COVID-19 pandemic will soon be an endemic and the market may shift fully away from "COVID-19 tickers". Insiders continue to dump shares. Since the start of 2022, insiders have...
Not financial advice. The essence of investing & trading is the intelligent and patient preying on the greed, fear, impatience, addiction and ignorance of the majority. It's definitionally Darwinian.
Pfizer will re-enter the channel below current support. Looking for a re-test and breakdown of $45 before mid March. Fraud, vaccine ineffectiveness, and blatant disregard for human health are just a few of the concerns here. For those less inclined to believe in science, COVID is over and these vaccine companies cannot rely on any future income comparable to this...
Moderna - Short Term - We look to Sell a break of 137.05 (stop at 147.24) A move through bespoke support at 140.00 and we look for extended losses. Closed below the 20-day EMA. The primary trend remains bearish. Our overall sentiment remains bearish looking for lower levels. We look to set shorts in the early trade. Our profit targets will be 108.99 and...
Pfizer looks to test $50, and possibly the gap around 46~ if things get really ugly. Omicron is looking really promising as granting significant immunity after infection, which should reduce demand for further vaccinations. These vaccines companies have YEARS of covid priced into their stocks... Short side is getting a bit long in the tooth for new entries,...
nature is healing, narrative is falling... it was never about ur health
Short play currently playing out on the 5min (Rising wedge). .... also adopting the '3-day' rule-following on from this significant drop. 140 ish support in play.
50sma has been an important moving average for this ETF. We see 3 consecutive tests of the 50sma as resistance and a bounce lower. As we see lower highs and lower lows, the bearish trend is confirmed. I expect we fail again and test the blue line ($144.5).
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 development programs in six modalities comprising...
Moderna is getting hot with Omicron Covid variant. It almost has no investment attractiveness from current levels, but it has potential for making some sort of reverse pattern (so we will probably see some upward movement in short-term) You can open potential long-term short positions from fibo levels (red lines) Dump it!
Hello everybody, As far as I understand, we are in the wave 3 of the wave 5. We surely can see some correctrion up to 275$ in the 4th wave. It would be nice top hear your ideas and views about this interpretation of Elliott Wave Principle on the example of Moderna stock